Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Corium International Inc (CORI)

NASDAQ
Currency in USD
Disclaimer
12.680
0.000(0.00%)
Real-time Data
CORI Scorecard
Fair Value
Unlock Value
Day's Range
12.65012.745
52 wk Range
0.00012.745
Prev. Close
12.65
Open
12.67
Day's Range
12.65-12.745
52 wk Range
0-0
Volume
0
Average Vol. (3m)
196,463
1-Year Change
0%
Shares Outstanding
36,517,802
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about CORI?
Vote to see community's results!
or

Corium International Inc Company Profile

Corium, LLC, a commercial-stage biopharmaceutical company, develops and commercializes central nervous system (CNS) therapies and pharmaceutical products. The company’s products include AZSTARYS, a central nervous system (CNS) stimulant prescription medicine for the treatment of attention deficit hyperactivity disorder (ADHD), and ADLARITY, a donepezil transdermal system for the treatment of mild, moderate, or severe dementia of the Alzheimer’s type. The company was formerly known as Corium International, Inc. and changed its name to Corium, LLC in March 2019. Corium, LLC was founded in 1999 and is based in Grand Rapids, Michigan with an additional location in Boston, Massachusetts.

Industry
-
Sector
-
Employees
213
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.